Wednesday, April 20, 2016 12:05:16 PM
It's really hard to fathom why Raefield put shareholders at such risk by saying those things. At least he is out now, but so far that hasn't helped the stock price one bit.
.03 - .04 may seem like nothing to current management but at this point it would make a huge difference to me if the stock would do that because I bought shares upon all the glowing endorsements by the prior CEO and continued to buy as it went down. I don't own a lot by any means, but enough that it has affected me financially.
I wish the new management would at least TRY and prop the price up if for no other reason out of respect for the shareholders that got shafted by all the prior mismanagement.
As bad as things are, at least this company is real, with 36 employees, and is on the 'cutting edge', as opposed to the vast majority of OTC companies with such a low market cap. They have enough under the hood that with simple promotion they could get the price up to at least the 5 cent area.
For microcap opportunities in the hot Virtual Reality sector, see my board
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM